Back
Catalyst Pharmaceuticals Stock Predictions
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
67
CPRX
Catalyst Pharmaceuticals
Last Price:
$23.35
Seasonality Move:
15.63%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Catalyst Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 30% based on the past 18 years of stock performance.
-
Catalyst Pharmaceuticals has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Catalyst Pharmaceuticals Stock Undervalued?The current Catalyst Pharmaceuticals [CPRX] share price is $23.65. The Score for CPRX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Catalyst Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 30% based on the past 18 years of stock performance.
Catalyst Pharmaceuticals Stock Rating
Buy
67
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals overpriced?
-
Catalyst Pharmaceuticals has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Catalyst Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com
52-Week Data
52-Week High:
26.16
52-Week Low:
14.75
Prediction Charts
Market Cap:
2.9B
Price in USD:
23.65
Volume:
1.1M
Beta:
1.09
Technical Analysis
SMA50:
23.08
SMA100:
22.63
SMA200:
21.51
52-Wk Change:
45.81%
Stock Predictions
-
Is Catalyst Pharmaceuticals stock public?Yes, Catalyst Pharmaceuticals is a publicly traded company.
-
What is the Catalyst Pharmaceuticals stock quote today?The Catalyst Pharmaceuticals stock price is 23.65 USD today.
-
How to buy Catalyst Pharmaceuticals stock online?You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-24 | 23.15 | 23.19 | 23.40 | 23.04 |
| Apr-25 | 23.12 | 23.45 | 23.51 | 22.90 |
| Apr-28 | 23.53 | 23.63 | 24.19 | 23.36 |
| Apr-29 | 23.53 | 24.28 | 24.46 | 23.41 |
| Apr-30 | 24.28 | 24.29 | 24.61 | 24.01 |
| May-1 | 24.28 | 24.27 | 24.65 | 23.81 |
| May-2 | 24.37 | 24.84 | 25.01 | 24.37 |
| May-5 | 24.78 | 24.30 | 24.83 | 24.18 |
| May-6 | 24.01 | 23.06 | 24.18 | 22.94 |
| May-7 | 23.10 | 23.46 | 23.59 | 23.00 |
| May-8 | 23.17 | 22.76 | 23.17 | 20.80 |
| May-9 | 23.06 | 23.37 | 23.70 | 22.89 |
| May-12 | 23.50 | 23.83 | 24.08 | 23.19 |
| May-13 | 23.98 | 23.65 | 24.07 | 23.31 |
Catalyst Pharmaceuticals Earnings
Catalyst Pharmaceuticals Earnings Report: Per Share Catalyst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Catalyst Pharmaceuticals Forecast Revenue Growth
Catalyst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.17 per share, an increase this year of $0.04 per share, and an increase next year of $0.25 per share.
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.